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NO-sensitive guanylyl cyclases are the most important
receptors for the signalling molecule NO. Activation of
guanylyl cyclase by NO leads to the formation of the intra-
cellular messenger cGMP. The enzyme is a heterodimer
which consists of two subunits, α and β. Three different
subunits exist in vivo: Two α subunits (α1 and α2) and oneβ subunit (β1). Functional enzymes are formed by het-
erodimerization. The two known guanylyl cyclase iso-
forms are composed of one of either α subunit and the β1
subunit (i.e. α1β1 and α2β1).
Although the function of NO-sensitive guanylyl cyclase
has been extensively studied during the last 30 years (e.g.
its role in smooth muscle relaxation, platelet inhibition,
leukocyte adhesion or neurotransmission) many func-
tions of the enzyme and its product cGMP await further
clarification.
In order to elucidate the role of NO-sensitive guanylyl
cyclase in vivo we generated mice in which the β1 subunit
of the enzyme was knocked out. Based on the fact that the
β1 subunit is the dimerizing partner for both α subunits,
we expect these mice not to show any cGMP formation
upon NO stimulation. Investigation of these mice will
provide further information on the importance of NO-
sensitive guanylyl cyclase.
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